[6] [7] Glutathione Injection should not be used in individuals with a known hypersensitivity or allergy to glutathione or any component of the formulation
Calcium oxalate (CaOx) crystal treatment obviously elevated the cellular iron concentration, enhanced lipid peroxidation, and reduced the expression of GPX4 and SCL7A11 in vivo and in vitro
On the other hand, a recent network meta-analysis [32] indirectly compared CV effects among different GLP-1RA in patients with T2DM and did not find any significant difference between GLP1RA in reducing death from any cause, MI and stroke events
Yang, Y., Wu, J., & Watson, J
In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
47 : 705711 Brooks JO, Yesavage JA, Carta A, Bravi D